Volume 30, Number 10—October 2024
Dispatch
Mpox Epidemiology and Vaccine Effectiveness, England, 2023
Table 2
Variable | No. (%), n = 128† |
---|---|
HIV status | |
Living with HIV | 13 (10) |
HIV negative | 69 (54) |
Taking HIV PrEP‡ | 51 (74) |
Not taking PrEP‡ | 18 (26) |
Unknown |
46 (36) |
Modified Vaccinia Ankara–Bavarian Nordic vaccination status§ | |
Vaccinated: >2 doses¶ | 30 (23) |
Vaccinated: 1 dose | 20 (16) |
Vaccinated: no. doses unknown | 2 (2) |
Unvaccinated | 54 (42) |
Unknown |
22 (17) |
Childhood smallpox vaccination status | |
Vaccinated | 4 (3) |
Unknown |
124 (97) |
Hospital admission | |
Yes | 11 (9) |
No | 117 (91) |
Unknown |
|
Reporting attending events involving multiple sex partners | |
Yes | 28 (22) |
No | 17 (13) |
Unknown | 83 (65) |
Concurrent STI |
|
Yes | 24 (19) |
No | 28 (22) |
Unknown | 76 (59) |
*Patients were median 36 years of age, range 19–70 years, interquartile range 29–24 years. PrEP, preexposure prophylaxis; STI, sexually transmitted infection. †Unless otherwise stated, denominators are 128; denominators for percentage calculations are HIV-negative persons. ‡We do not have information on HIV treatment or outcomes of treatment for these cases. Nevertheless, most people living with HIV in England take antiretroviral therapy and have an undetectable viral load (8). §Estimated date of vaccination was available for 33 out of 52 vaccinated cases, all of whom received the Modified Vaccinia Ankara–Bavarian Nordic vaccine >2 weeks before infection. ¶Includes 1 person who reported receiving 3 doses.
References
- UK Health Security Agency. Monkeypox outbreak: technical briefing 8 [cited 2024 Feb 14]. https://www.gov.uk/government/publications/monkeypox-outbreak-technical-briefings/investigation-into-monkeypox-outbreak-in-england-technical-briefing-8
- UK Health Security Agency. Mpox (monkeypox) outbreak: epidemiological overview [cited 2024 Feb 14]. https://www.gov.uk/government/publications/monkeypox-outbreak-epidemiological-overview
- UK Health Security Agency. Mpox (monkeypox): case definitions [cited 2024 Feb 14]. https://www.gov.uk/guidance/monkeypox-case-definitions
- UK Health Security Agency. Reporting to UKHSA: a guide for diagnostic laboratories [cited 2024 Feb 14]. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1159953/UKHSA_Laboratory_reporting_guidelines_May_2023.pdf
- UK Health Security Agency. Notifiable diseases and causative organisms: how to report [cited 2024 Feb 14]. https://www.gov.uk/guidance/notifiable-diseases-and-causative-organisms-how-to-report
- Flannery B, Andrews N, Feikin D, Patel MK. Commentary: Estimation of vaccine effectiveness using the screening method. Int J Epidemiol. 2023;52:19–21. DOIPubMedGoogle Scholar
- Bertran M, Andrews N, Davison C, Dugbazah B, Boateng J, Lunt R, et al. Effectiveness of one dose of MVA-BN smallpox vaccine against mpox in England using the case-coverage method: an observational study. Lancet Infect Dis. 2023;23:828–35. DOIPubMedGoogle Scholar
- UK Health Security Agency. HIV action plan monitoring and evaluation framework [cited 2024 Apr 25]. https://www.gov.uk/government/publications/hiv-monitoring-and-evaluation-framework
- Chicago Health Alert Network. Potential risk for new mpox cases—provider update: May 9, 2023 [cited 2024 Feb 14]. https://emergency.cdc.gov/han/2023/han00490.asp
- Chicago Department of Public Health. Mpox dashboard [cited 2024 Feb 14]. https://www.chicago.gov/city/en/depts/cdph/provdrs/infectious_disease/supp_info/mpox-home/mpox-dashboard.html
- World Health Organization. Multi-country outbreak of mpox: external situation report #31—22 December 2023 [cited 2024 Feb 14]. https://www.who.int/publications/m/item/multi-country-outbreak-of-mpox--external-situation-report-31---22-december-2023
Page created: August 27, 2024
Page updated: September 23, 2024
Page reviewed: September 23, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.